Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

株式のランク #3228
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
株価
$33.33
最終同期: 2026-10-19
時価総額
$5.50B
変化(1日)
-0.68%
変化(1年)
52.16%
国
IN
取引 Gland Pharma Limited (GLAND)

カテゴリー

Healthcare
Gland Pharma Limited(GLAND)のEPS
June 2026 時点のEPS TTM: $0.76
Gland Pharma Limitedの最新の財務報告と株価によると、同社の現在のEPS(TTM)は$0.76です。2024年末には、EPSは$0.56で、2023年のEPS$0.58と減少でした。
Gland Pharma LimitedのEPS履歴(2017から2026まで)
各年末時点のEPS
年 EPS 変化
2026 (TTM) $0.76 51.22%
2025 $0.50 -11.86%
2024 $0.56 -2.56%
2023 $0.58 -40.63%
2022 $0.97 12.85%
2021 $0.86 30.13%
2020 $0.66 57.68%
2019 $0.42 31.96%
2018 $0.32 -22.71%
2017 $0.41 0.00%